SUIC Worldwide Holdings Ltd.

SUIC Worldwide Holdings Ltd. has acquired a 51% stake in Taiwan Vision Renu Corporation through a share exchange agreement. The transaction involved 30,000,000 shares of SUIC Common Stock, representing approximately 35% of SUIC's fully-diluted outstanding shares. Following the acquisition, SUIC's Board of Directors was reconstituted, with Chen King Te appointed as Chairman, Director, and CEO, and Shan Hua Peng as Director and CFO. Vision Renu, specializing in high-tech medical devices like a Scleral Micro-Ablation Laser System and a Transcranial Magnetic Stimulation (TMS) device, anticipates significant growth in unit orders over the next three years and plans to enter the life science sector.

SUIC Worldwide Holdings Ltd. reported a net loss of $(15,035) for the three months ended March 31, 2026, significantly narrowing from $(29,981) in the prior year period. The company generated $20,000 in consulting revenue, up from $0 in the previous year, but continues to face substantial doubt about its ability to continue as a going concern due to a working capital deficit and accumulated deficit. Management is actively seeking external financing and new business ventures to mitigate this situation.